* Cerus Corp CERS.OQ reported a quarterly adjusted loss of
1
cent per share for the quarter ended December 31, identical to
the same quarter last year. The mean expectation of
six analysts for the quarter was for a loss of one cent per
share. Wall Street expected results to range from -2 cents to -1
cents per share.
* Revenue rose 8.6% to $50.81 million from a year ago;
analysts
expected $49.64 million.
* Cerus Corp's reported EPS for the quarter was a loss of 1
cent.
* The company reported a quarterly loss of $2.52 million.
* Cerus Corp shares had risen by 17.5% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Cerus Corp is
$4.00
This summary was machine generated from LSEG data February 20 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.01 -0.01 Met
Sep. 30 2024 -0.03 -0.02 Beat
Jun. 30 2024 -0.04 -0.03 Beat
Mar. 31 2024 -0.05 -0.05 Met